Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-28

Clinical Trial Update: Examining Written Disclosure as a Treatment for Post-Traumatic Stress Disorder [NA]

View source ↗

Summary

A completed clinical trial evaluating written disclosure as a treatment for post-traumatic stress disorder, sponsored by Boston University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston University | Conditions: Post-Traumatic Stress Disorder | NA | Status: COMPLETED